|
||||||||||||||||
PIHP Questions
From
|
||||||||||||||||
|
These are questions from our “Partnering for Success” Annual Meeting 4/12/07. We have all of your responses from the guided questions section of this meeting as well. We are using those responses as we go forward with implementation and thank you for your input in this process. It is clear from those responses that our system has great strength to build on! The questions below represent about three quarters of all of the questions we captured at this meeting. We are in the process of researching the others and plan to post those on this site as soon as possible. Once again, thank you for your valuable input in this process and we look forward to your continued questions through the question/answer section of this web site.
General Questions Q1. In other States what are some of the prevention components
or dollars with ValueOptions? Q2. Will ValueOptions be offering IT support for the KCPC Program? Q3. Are there dollars available to Dr’s offices serving pregnant
women who are using substance abuse; to do screenings assessments and brief interventions
in office to identify these women for other treatment options? Q4. Will Claims be submitted through existing KCPC? A. Claims for dates of service prior to July 1, 2007 should be submitted per the current procedures in Kansas. For example, to the claim address on the member’s Kansas Medicaid ID card or through the KCPC billing system depending on funding source of services. Any questions regarding claims for these dates of service should be directed to the Kansas Medicaid customer service number listed on the member’s ID card or to the State for KCPC billing questions per the current process. All claims for eligible Medicaid enrollees for services covered under the SA-PIHP with dates of service of July 1, 2007 or after that have already been pre authorized by the current vendor will be honored and paid by ValueOptions. Claims for eligible Medicaid enrollees for services covered under the SA-PIHP for services rendered by participating ValueOptions providers with dates of service of July 1, 2007 and after should be submitted to ValueOptions [Luton, Julie] via www.valueoptions.com <http://www.valueoptions.com/> . ValueOptions accepts electronically submitted claims generated from ValueOptions’ EDI Claims Link for Windows® software or from your Practice Management System.
Q5. Currently youth are
eligible (financially) for AAPS-funded treatment if the family has an income
of 200% or less of FPG. Will this be continued? Q6. What population will be served by the Valueoptions funding? Q7. What components make up the partnership? Q8. Will there continue to be a cap? Q9. Will ValueOptions recruit new providers for the
Medicaid or Block Grant Program? Q10. I currently am participating in the ValueOptions Commercial/Non-HMO
Network; will I have to negotiate a separate contract and reimbursement rate
for services? Q11. As a Medicaid provider will I automatically participate in the ValueOptions
Commercial/Non-HMO Network? Clinical, Authorization and Quality Services Q14. Will Valueoptions cover medications such as Anabuse, Vivatrol etc?
How about lab work? Q15. How will use of new medications available to assist with early
abstinence be factored into the new plan? Q16. What plans do you have to coordinate efforts with the department
of corrections? Q17. Will Valueoptions manage non-Medicaid clients? Q18. How will Valueoptions manage court coerced unmotivated clients? Q19. Other than the KCPC for initial authorization how will providers
be authorized for further services on consumers? What type of documentation will
be submitted to Valueoptions? Q20. How is medical necessity defined especially for outpatient? Q21. Will Valueoptions be coordinating with Kansas Health Solutions (PAHP for mental health) in providing integrated dual diagnosis treatment to consumers with Medicaid? A. Valueoptions is currently meeting with the state to discuss enhancing co-occurring disorder strategies with the mental health partners Q22. Will continuing care or after care be paid for as step-down level of care? A. Yes, when authorized Q23. Can you estimate the amount of administrative time for UR per client? Q24. We provide long term reintegration treatment for women and women
with children. Will a 6 month treatment program or long term treatment be affected? Q25. What can Valueoptions of Kansas do for our agency? Where do we fit
in this system (halfway house?) Q26. How did the agency reduce its 5 week waiting list for inpatient services with patients? A. By following the level of care criteria provided in ASAM, you can gain a lot of guidance on establishing a person’s current motivation for treatment and their readiness for change. By using the level of care criteria we are sure that members are placed in the appropriate level of treatment needed for their presenting conditions. ASAM gives guidance for the need for continued stay in treatment. By working with providers Valueoptions will use ASAM to improve the clinical appropriateness of care and hopefully reduce waiting lists. Q27. Is Valueoptions going to understand and utilize NIDA principles when
considering authorizations for treatment services? Q28. Is there risk of denial/refusal of services to court ordered or coercion
because of consumers’ lack of or low motivation? Q29. Is there risk of denial/refusal based on number of treatment episodes? Q30. How will Valueoptions want us to handle the chronic recidivism client? Q31. How will we have to handle discharges? Q32. How will Valueoptions reconcile early intervention services with
ASAM criteria for medical necessity? Q33. How will you provide 24 hour crisis services for substance abuse
clients?
Provider Relations Q34. If substance abuse agency has licensed clinicians for co-occurring
disorders do you have to refer to the MH clinics or can agency provide and get
paid? Q35. What are the minimum provider credentials? A. ValueOptions has established a specialized Agency Credentialing application tailored for the State of Kansas Provider network. Provider requirement are outlined in the Agency credentialing application.
Claims
Q36. Treating co-occurring
disorders is encouraged. However, how will it be determined who will pay for
the service? | ||||||||||||||||
|
||||||||||||||||